Universe Pharmaceuticals (UPC) Current Deferred Tax Assets (2021 - 2022)

Universe Pharmaceuticals has disclosed Current Deferred Tax Assets across 2 years of filings, most recently posting $7.6 million for Q1 2022.

• Current Deferred Tax Assets for Q1 2022 came in at $7.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $7.6 million (changed N/A YoY), and the FY2021 annual result was $7.5 million, changed N/A from the prior year.
• Current Deferred Tax Assets came in at $7.6 million for Q1 2022 at Universe Pharmaceuticals, up from $7.5 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $7.6 million in Q1 2022 to a low of $7.5 million in Q3 2021.